Women

Questions discussed in this category

Do you frequently recommend the HPV vaccination series to patients above 26 years old?

What patient factors would make you more likely to recommend? Cost-effectiveness discussion as published in Annals of Internal Medicine: Laprise et al...

1 Answer available

Would you consider using transdermal estrogen in a patient with “high risk” APLS patient on warfarin?

Both VTE and arterial thrombosis (CVA) prior to starting warfarin. Lupus anticoagulant positive. Has severe post menopausal symptoms.

1 Answer available

How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE?

Risk factors such as hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc.

2 Answers available

What strategies do you recommend for discussing the use of OCP in women with a history of migraines with or without aura?

In light of publication from Ihara et al in Cephalagia 2025 Dec

2 Answers available

How to you approach the risk/benefit discussion for hormone replacement therapy in perimenopausal women with significant vasomotor symptoms and borderline ASCVD risk?

1 Answer available

What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?

1 Answer available

Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?

1 Answer available

How do you view the risk of tardive dysinesia and other side effects in your female patients with treatment-resistant depression who are stable on an atypical antipsychotic?

Given the concern about potential TD in female patients treated with second-generation atypical antipsychotics as an adjunct to antidepressants, are y...

5 Answers available

Do you consider co-prescribing hormone therapy and anticoagulation in a patient with prior DVT and uncontrollable VSM uncontrolled by non-hormonal therapies?

4 Answers available

How do you decide whether average-risk patients should undergo annual or biennial breast cancer screening?

1 Answer available